1. Home
  2. MDWD vs BPRN Comparison

MDWD vs BPRN Comparison

Compare MDWD & BPRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • BPRN
  • Stock Information
  • Founded
  • MDWD 2000
  • BPRN 2007
  • Country
  • MDWD Israel
  • BPRN United States
  • Employees
  • MDWD N/A
  • BPRN N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • BPRN Major Banks
  • Sector
  • MDWD Health Care
  • BPRN Finance
  • Exchange
  • MDWD Nasdaq
  • BPRN Nasdaq
  • Market Cap
  • MDWD 195.2M
  • BPRN 217.9M
  • IPO Year
  • MDWD 2014
  • BPRN N/A
  • Fundamental
  • Price
  • MDWD $19.47
  • BPRN $29.75
  • Analyst Decision
  • MDWD Strong Buy
  • BPRN Strong Buy
  • Analyst Count
  • MDWD 2
  • BPRN 1
  • Target Price
  • MDWD $35.00
  • BPRN $35.00
  • AVG Volume (30 Days)
  • MDWD 83.0K
  • BPRN 11.4K
  • Earning Date
  • MDWD 11-25-2025
  • BPRN 10-24-2025
  • Dividend Yield
  • MDWD N/A
  • BPRN 3.89%
  • EPS Growth
  • MDWD N/A
  • BPRN N/A
  • EPS
  • MDWD N/A
  • BPRN 1.00
  • Revenue
  • MDWD $19,858,000.00
  • BPRN $68,942,000.00
  • Revenue This Year
  • MDWD $21.39
  • BPRN $13.82
  • Revenue Next Year
  • MDWD $23.01
  • BPRN $15.85
  • P/E Ratio
  • MDWD N/A
  • BPRN $30.90
  • Revenue Growth
  • MDWD N/A
  • BPRN N/A
  • 52 Week Low
  • MDWD $14.14
  • BPRN $27.25
  • 52 Week High
  • MDWD $22.51
  • BPRN $39.35
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 66.30
  • BPRN 34.00
  • Support Level
  • MDWD $17.72
  • BPRN $30.00
  • Resistance Level
  • MDWD $18.54
  • BPRN $31.00
  • Average True Range (ATR)
  • MDWD 0.62
  • BPRN 0.57
  • MACD
  • MDWD 0.22
  • BPRN -0.10
  • Stochastic Oscillator
  • MDWD 86.01
  • BPRN 2.30

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

Share on Social Networks: